Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Cytarabine |
| Active Ingredient: | Cytarabine 20mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer (Perth) Pty Limited, Perth, Australia Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India |
| Product: | Imatis |
| Active Ingredient: | Imatinib mesilate 119.5mg equivalent to imatinib 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Kapakli, Turkey |
| Product: | Imatis |
| Active Ingredient: | Imatinib mesilate 478mg equivalent to imatinib 400mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Kapakli, Turkey |
Dated this 23rd day of January 2024.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).